Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
데이터 추가 비고
원인
There is an increased rate of very major errors (vme) for colistin with colistin resistant strains of the enterobacteriaceae (17.5%). this percentage is derived from a recently-concluded external study and likely involve emerging hetero-resistant strains.